Immune Response in the SAPHO Syndrome

To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS

NCT02311842 ·Status: COMPLETED

Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis

NCT00580632 ·Status: COMPLETED

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

NCT03419143 ·Status: COMPLETED

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599 ·Status: COMPLETED ·Phase: PHASE2

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

NCT00432406 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

Prospective Evaluation of the Radiographic Efficacy of Enbrel

NCT01623752 ·Status: COMPLETED

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

NCT01298531 ·Status: COMPLETED ·Phase: PHASE4

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

NCT02115750 ·Status: COMPLETED ·Phase: PHASE3

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

NCT02486302 ·Status: COMPLETED

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan

NCT02335606 ·Status: COMPLETED

Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

NCT01118728 ·Status: TERMINATED ·Phase: PHASE2

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

NCT01578850 ·Status: COMPLETED ·Phase: PHASE4

Ultrasound Enthesitis Response in Psoriatic Arthritis

NCT03955861 ·Status: COMPLETED

Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis

NCT02638896 ·Status: UNKNOWN ·Phase: PHASE4

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

NCT03457792 ·Status: COMPLETED

A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects

NCT01011959 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain

NCT00873730 ·Status: COMPLETED ·Phase: PHASE4

Socio-economic Determinants for Acceptance and Choice of Biological Treatment

NCT04369651 ·Status: COMPLETED

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs

NCT04077957 ·Status: UNKNOWN ·Phase: PHASE4

Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients

NCT04645420 ·Status: COMPLETED ·Phase: NA